Cold chain

This photo shows the SAVSU containers for temperature-sensitive shipments.
Feature Article
|

Assessing trends in temperature-sensitive biologic shipments

In this 'First Person' Q&A, Mike Rice, President & CEO, BioLife Solutions, Inc., discusses the role of a smart shipping container and a related cloud-hosted ‘cold chain’ management app.
E-Book Special Report
Total Cost of Ownership
Sign up to receive timely updates from our editors and download this E-Book Special Report to learn how to calculate the true Total Cost of Ownership (TCO) of your packaging machinery.
Schematic of Cryoport’s liquid nitrogen dry vapor shipper.
News
|

Sanaria uses logistics partnership to support Malaria vaccines

Cryoport, Inc. a provider of advanced cryogenic logistics products for the life sciences industry, is enhancing its cryogenic logistics support of its Sanaria partnership, which includes Sanaria’s production of malaria vaccine as well as its research and development efforts.
News
|

Global healthcare cold chain market to reach $13.4 billion

An increase demand for a certain type of product is driving the growth, according to a new report.
CombiMatrix selects Cryoport as logistics partner. Here we see a Cryoport shipper in transit.
News
|

CombiMatrix selects Cryoport as logistics partner

Clinical diagnostic laboratory CombiMatrix teams with Cryoport for the distribution of its new CombiPGS™ genetic screening test.
Kevin O'Donnell is Vice President, Cold Chain Standards, Practices & Compliance at BioLife Solutions, Inc., and is a Contributin
Column/Opinion
|

Test your cold chain IQ

True or false questions about the handling of biologics and drugs in the supply chain.
Among survey respondents, 52.1% are involved in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and diagnostic
News
|

Survey uncovers key trends in temperature-controlled packaging

What to look for in the next two to three years in pharmaceutical logistics and temperature-sensitive healthcare markets.
Kevin O’Donnell, Senior Partner, Exelsius, is a noted authority in supply chain integrity.
Column/Opinion
|

Reevaluating drug product stability can save millions on packaging

Kevin O’Donnell, Senior Partner, Exelsius, is a noted authority in supply chain integrity. In this Q&A he lends his “big-picture” insights regarding distribution practices for time and temperature-sensitive pharmaceutical/biological products.
FIGURE 1: Experimental set-up: Monitoring set-up in the lab showing three VisiSens detection units (cameras on the right corner) connected to a PC and software screen (a); test vial containing alginate beads in direct contact with the detector unit for CO2 monitoring (b); monitoring set-up allows detection of three parameters pH, O2 and CO2 (c).
Feature Article
|

Immobilized plant cells: from DSMZ to the customer

VisiSens technology is used to detect metabolic activities of immobilized plant cells during simulated cell transport in a closed system.
'Explosive growth' projected for cold chain logistic services
News
|

'Explosive growth' projected for cold chain logistics services

Events in Boston and Frankfurt, Germany to reveal late-breaking developments in temperature-controlled packaging, distribution, and logistics.
'Cold Chain Chronicles' delivers thought-provoking insights
Column/Opinion
|

'Cold Chain Chronicles' delivers thought-provoking insights

New book authored by Kevin O’Donnell provides practitioner’s outside-the-box perspectives on the importance of temperature-sensitive drug stewardship.

Pages

Subscribe to Cold chain

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
PACKAGING MACHINERY
SPECIAL INTEREST
PACK EXPO
Each newsletter ranges in frequency from once per month to a few times per month at most.